Mouse PD-1[Biotinylated]:PD-L1 Inhibitor Screening Assay Kit

Catalog #
72027
$1,300 *
Size: 96 reactions
Qty
*US Pricing only. For international pricing, please contact your local distributor.
Purchase
Description

The Mouse PD-1[Biotinylated]:PD-L1 Inhibitor Screening Assay Kit is designed for screening and profiling inhibitors of this signaling. The key to this kit is the high sensitivity of detection of biotin-labeled PD-1 by streptavidin-HRP. Only a few simple steps on a microtiter plate are required for the assay. First, mouse PD-L1 is coated on a 96-well plate. Next, mouse PD-1 is incubated with mouse PD-L1 on the plate. Finally, the plate is treated with streptavidin-HRP followed by addition of an HRP substrate to produce chemiluminescence, which can then be measured using a chemiluminescence reader.

Need us to run inhibitor screens or profile your compounds against Mouse PD-1[Biotinylated]:PD-L1? Check out our Immunotherapy Biochemical Screening Services.

Synonyms
Programmed cell death 1, PDCD1, PD-1, PD1, SLEB2, CD279, HPD-L and Programmed Cell Death 1 Ligand 1, CD274, B7 homolog 1 (B7-H1), activity assay kit, PDL1
Product Info
Storage and Usage
Citations
Assay Kit Format
Chemiluminescent
Species
Mouse
Supplied As
This kit comes in a convenient 96-well format, with biotin-labeled mouse PD-1, purified mouse PD-L1, streptavidin-labeled HRP, and assay buffer for 100 binding reactions.
Format
Catalog # Component Amount Storage
71117 Mouse PD-L1, Fc fusion* 30 µg -80°C





Avoid

freeze/
thaw
cycles
71118 Mouse PD-1, Fc fusion, Biotin-labeled* 10 µg -80°C
79742 Streptavidin-HRP 10 µl +4°C
  3x Mouse PD-1 Assay Buffer 50 ml -20°C
79728 Blocking Buffer 2 50 ml +4°C
79670 ELISA ECL substrate A
(transparent bottle)

6 ml
Room
Temp.
ELISA ECL substrate B
(brown bottle)

6 ml
Room
Temp.
79699 White 96-well microplate 1 +4°C

 

 

 

 

 

 

 

 

 

 

 

 

 

 

*The concentrations of Mouse PD-L1 and Mouse PD-1 are lot-specific and will be indicated on the tubes containing the protein.

Background
Cell signaling through the PD-1 receptor upon binding the PD-L1 ligand attenuates immune responses and is exploited by both tumors and viruses for immune evasion.
References

1. Lin, D., et al. Proc. Natl. Acad. Sci. USA. 2008, 105: 3011-3016.
2. Keir, M.E., et al. Annu. Rev. Immunol. 2008, 26: 677-704.